Post‐exposure prophylaxis for HIV infection in sexual assault victims von Inciarte, A, Leal, L, Masfarre, L, Gonzalez, E, Diaz‐Brito, V, Lucero, C, Garcia‐Pindado, J, León, A, García, F, Manzardo, C., Nicolás, D., Bodro, M., Río, A., Cardozo, C., Cervera, C., Pericás, J. M., Sanclemente, G., García‐Pindado, J., Cobos, N., Calle, C., Calle, C., Morata, L., Soriano, A., Espinosa, G., Echeverría, T., Céspedes, F., Farràs, U., Rodríguez, D., Martínez, B., Suárez, M., Gahete, A., Santiñá, M., García, L. L.

Volltext

193P Differences in response to immunotherapy between KRAS G12C and KRAS non-G12C mutated NSCLC von Pinto, L. Masfarre, Rocha, P., Clave, S., Gorro, N. Navarro, Sanchez, I., Giner, M., Lloret, A. Corbera, Garcia, A. Taus, Parreira, A.S.D.F.M., Paricio, B. Bellosillo, Arriola, E.

Volltext

P3.13C.06 Artificial Intelligence Meets SCLC - Integrating Clinicopathological and Whole-Slide Image Data for Prognostic Prediction in SCLC von Rocha, P., Gibert, J., Menendez, S., del Rey-Vergara, R., Iñañez, A., Masfarre, L., Navarro, N., Rios-Hoyo, A., Perez, S., Taus, Á., Giner, M., Rovira, A., León-Mateos, L., Isla, D., Paz-Ares, L., Zugazagoitia, J., Martí Blanco, C., García-Campelo, R., Moreno-Vega, A., Callejo, A., Rojo, F., Sanchez, I., Arriola, E.

Volltext

P2.11A.08 Molecular and Immunological Features Associated with Long-Term Benefit in Metastatic NSCLC Patients Undergoing Immune Checkpoint Blockade von Rocha, P., Bach, R., Masfarre, L., Hernandez, S., Navarro-Gorro, N., Rossell, A., Villanueva, X., Giner, M., Sanchez, I., Galindo, M., del Rey-Vergara, R., Iñañez, A., Sanchéz-Espiridion, B., Lu, W., Acedo-Terrades, A., Berenguer-Molins, P., Sánchez-Font, A., Chalela, R., Curull, V., Taus, Á., Hardy-Werbin, M., Sausen, M., Georgiadis, A., White, J., Jackson, J.B., Moliner, L., Clavé, S., Bellosillo, B., Rovira, A., Wistuba, I., Solis Soto, L.M., Perera-Bel, J., Arriola, E.

Volltext

165P SCLC subtypes are associated with distinct dinicopathological features and outcomes: A biomarker analysis from the CANTABRICO study von Rocha, P., Sanchez, I., Pinto, L. Masfarre, Giner, M., Gorro, N. Navarro, Hoyo, A. Rios, Garcia, A. Taus, Pérez-Buira, S., Torres-Fernandez, É., Clave, S., Paricio, B. Bellosillo, Rojo, F., Paz-Ares, L., Cubells, C. Martí, de la Rosa, C. Aguado, Casado, M.D. Isla, Garcia-Campelo, R., Baez, L., Mellén, Á. Callejo, Arriola, E.

Volltext

55P Differences in response to immune treatment between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer von Pinto, L. Masfarre, De Freitas Matos-Parreira, A.S., Unanua, N. Castro, Da Rocha, P.F. Simoes, Ruiz, I. Morilla, Sanchez, L. Teijeira, Clave, S., Gorro, N. Navarro, Mora, R. Bach, Sánchez, I., Galindo Campos, M.A., Garcia, A. Taus, Martínez, A. Azkárate, Fabregat, R. Marse, Paricio, B. Bellosillo, Arasanz, H., Aguillo, M. Martínez, Gómez, C., Company, A., Arriola, E.

Volltext

1410P Characterization of patients with advanced non-small-cell lung cancer (NSCLC) harboring KRASG12C mutation and their associated direct healthcare costs in Spanish routine clin... von Reguart Aransay, N., Sánchez, J., Juan Vidal, O.J., Aguilo Domingo, M., Arriola, E., López, C., Botella, X., Cots, F., Montironi, C., Palanca, S., Borràs, E., Masfarre Pinto, L., Planellas, L., Lloansi Vila, A.

Volltext

1386P Validation of MET amplification using next-generation sequencing in lung adenocarcinoma von Salido, M., Clavé, S., Sánchez, I., Rocha, P., Masfarre Pinto, L., Navarro Gorro, N., Galindo Campos, M.A., Del Rey-Vergara, R., Taus Garcia, A., Espinet, B., Arriola, E., Bellosillo Paricio, B.

Volltext

1451P Identifying long-term responders to immune checkpoint blockade: Potential utility of serum proteomic profiling in metastatic non-small cell lung cancer von Bach Mora, R., Rocha, P., Masfarre Pinto, L., Navarro Gorro, N., Rossell, A., Gonzalez, S., Villanova, X., Giner, M., Sánchez, I., Galindo Campos, M.A., Del Rey-Vergara, R., Iñañez, A., Taus Garcia, A., Moliner, L., Hardy-Werbin, M., Clave, S., Bellosillo Paricio, B., Rovira, A., Perera-Bel, J., Arriola, E.

Volltext

1408P Differences on immune biomarkers between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer von Masfarre Pinto, L., Parreira, A.S.D.F.M., Castro Unanua, N., Rocha, P., Morilla Ruiz, I., Teijeira Sanchez, L., Clave, S., Navarro Gorro, N., Bach Mora, R., Sánchez, I., Galindo Campos, M.A., Taus Garcia, A., Azkárate Martínez, A., Marse Fabregat, R., Bellosillo Paricio, B., Arasanz, H., Martínez Aguillo, M., Arriola, E.

Volltext

P3.03I.12 Modulation of EMT Increases the Activity of Lurbinectedin in Small Cell Lung Cancer von Iñañez, A., del Rey-Vergara, R., Quimis, F., Masfarré, L., Navarro-Gorro, N., Taus, Á., Rovira, A., Arriola, E.

Volltext

Impact of Lymphopenia on Treatment Outcomes in Unresectable Non-Small Cell Lung Cancer von Amorelli, F., Martinez, A., Liu, F., Foro, P., Algara, M., Sanz, J., Membrive, I., Taus, A., Arriola, E., Masfarré, L., Navarro, N., De Dios, N. Rodriguez

Volltext

1776P Analysis of potencial drug interactions in oncologic patients diagnosed with COVID-19 von Fernandez Sala, X., Casadevall Aguilar, D., Masfarré, L., Conde-Estévez, D.

Volltext

167P KRAS G12C lung adenocarcinoma represents a distinct group of patients with different response to immunotherapy von Masfarré, L., Rocha, P., Clavé, S., Moliner, L., Navarro-Gorro, N., Ríos-Hoyo, A., Sánchez, I., Giner, M., Corbera, A., Taus, A., Bellosillo, B., Arriola, E.

Volltext

EP14.05-002 Impact of Body Mass Index on Survival in Patients with Small Cell Lung Cancer von Rios-Hoyo, A., Masfarré, L., Navarro-Gorro, N., Rocha, P., Galindo-Campos, M.A., Vergara, R. del Rey, Taus, Á., Arriola, E.

Volltext

49P Identifying peripheral immune predictors of durable clinical response to PD-L1 blockade in small cell lung cancer von Galindo Campos, M.A., Hardy-Werbin, M., Rios Hoyo, A., Gibert, J., Rossell, A., Gonzalez, S., Simoes da Rocha, P.F., Del Rey-Vergara, R., Masfarré, L., Navarro Gorro, N., Taus Garcia, A., Rovira, A., Arriola, E.

Volltext

91P Preexisting tumor host immunity delineates clinical outcomes in resectable non-small cell lung cancer von Rocha, P., Rodrigo, M., Moliner, L., Ríos-Hoyo, A., Masfarré, L., Navarro-Gorro, N., Menendez, S., Taus, A., Rodríguez, A., Aguiló, R., Belda, J., Del Rey-Vergara, R., Galindo, M., Comerma, L., Arriola, E.

Volltext

1726P Expanding the role of medical oncologist in the management of COVID-19 von Ghiglione, L., Auclin, E., Aguilar-Company, J., Epaillard, N., Casadevall Aguilar, D., Masfarré, L., Rodriguez Castells, M., Tagliamento, M., Pilotto, S., Lopez Castro, R., Mielgo Rubio, X., Urbano Centella, C., Laguna, J.C., García-Illescas, D., Bluthgen, M.V., Gorría Puga, T., Minatta, J.N., Cruz, C.A., Prat, A., Mezquita, L.

Volltext

1681P First results of the COCO study: COVID-19 outcomes in patients with cancer von Seguí, E., García de Herreros, M., Auclin, E., Mirallas, O., Casadevall, D., Rodriguez, M., Epaillard, N., Tagliamento, M., Pilotto, S., López-Castro, R., Mielgo, X., Urbano, C., Pesántez, D., Saoudi, N., Bluthgen, M.V., Masfarré, L., Minatta, J.N., Cruz, C.A., Mezquita, L., Prat, A.

Volltext

1713P Active smoking and severity of COVID-19 infection in cancer patients von Marta, G.D.H., Auclin, E., Saoudi Gonzalez, N., Casadevall Aguilar, D., Rodriguez Castells, M., Epaillard, N., Tagliamento, M., Pilotto, S., López-Castro, R., Mielgo Rubio, X., Urbano Centella, C., Pineda, E., Laia, F.M., Mirallas, O., Bluthgen, M.V., Masfarré, L., Minatta, J.N., Cruz, C.A., Prat, A., Mezquita, L.

Volltext